Neuroprotection for ischaemic stroke: translation from the bench to the bedside (Q37991061)

26 August 2017

title

Neuroprotection for ischaemic stroke: translation from the bench to the bedside (English)

1 reference

26 August 2017

1 reference

26 August 2017

Francesco Arba

0 references

Brad A Sutherland

0 references

Christoph Kleinschnitz

series ordinal

object named as

Christoph Kleinschnitz

1 reference

26 August 2017

Jens Minnerup

1 reference

26 August 2017

Joyce S Balami

series ordinal

1 reference

26 August 2017

publication date

6 March 2012

1 reference

International Journal of Stroke

26 August 2017

published in

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

407-418

1 reference

Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

1,026 experimental treatments in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotection for ischemic stroke: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Update of the stroke therapy academic industry roundtable preclinical recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotection for ischemic stroke: two decades of success and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Improving outcome after stroke: overcoming the translational roadblock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Lost in translation: taking neuroprotection from animal models to clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

New Approaches to Neuroprotective Drug Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Multifunctional actions of approved and candidate stroke drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Metabolic downregulation: a key to successful neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Effects of hypothermia on excitatory amino acids and metabolism in stroke patients: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Induced hypothermia for acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Feasibility and safety of moderate hypothermia after massive hemispheric infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotective agents for the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Statins: multiple mechanisms of action in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Effects of NXY-059 in experimental stroke: an individual animal meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

NXY-059 for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

NXY-059: brain or vessel protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Cosmic implications of NXY-059.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it before

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Mechanisms of action of neuroprotectants in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Ischemic stroke in the elderly: an overview of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The molecular control of hematopoiesis: From clonal development in culture to therapy in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

A systematic review and meta-analysis of erythropoietin in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Recombinant human erythropoietin in the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

EPO for stroke therapy - Is there a future for further clinical development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Free radicals in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Reactive oxygen species and the modulation of stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Role of oxidative stress in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Novel isoforms of NADPH-oxidase in cerebral vascular control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

NOX4: A Guilty Party in Stroke Damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

Primate work faces German veto

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2012.00770.X

10.1111/J.1747-4949.2012.00770.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference